Search Results

January 23, 2019  

The Grapevine

Biotechnology-stock specialist Nikhil “Nik” Khetarpal, formerly a managing director at shuttered hedge fund firm Tourbillion Capital, landed this month at Roivant Sciences. Khetarpal left Tourbillion in 2017 following stops at Balyasny Asset Management, Soros Fund Management, Citadel’s PioneerPath Capital and Credit Suisse. Roivant, founded by former QVT Financial partner Vivek Ramaswamy, builds single-product companies around...

This article is free to subscribers of Hedge Fund Alert. If you are a subscriber, please sign in.

If you are not a subscriber, please complete the form below to purchase the article for $19.95.
First Name *
Last Name *
E-mail *
Card Number *
Expiration *
Card Code *
Address *
City *
State/Province *
Zip/Postal Code *

Purchase Article